First-line therapeutic strategy for patients with advanced non-small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis

• Κύριοι συγγραφείς: Chongxiang Chen (Συγγραφέας), Chunning Zhang (Συγγραφέας), Huaming Lin (Συγγραφέας), Qianyin Liu (Συγγραφέας), Limian Wu (Συγγραφέας), Chengzhi Zhou (Συγγραφέας), Jiexia Zhang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: SAGE Publishing, 2022-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Aim: The objective of this network meta-analysis was to determine the most useful first-line therapeutic strategy for patients with advanced (IIIB/IV or relapsed) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Leu858Arg or EGFR 19del mutations. Methods: PubMed, the W...